Ellex is passionate about developing relationships with ophthalmologists, optometrists, GPs and procurement professionals to help more people around the world benefit from innovative, proven and safe ways to treat their eye conditions.
We believe that our technology can make a significant contribution to achieving this goal.
Experienced ophthalmologists everywhere are focused on achieving the very best results for their patients, with procedural pathways developed and perfected over years of implementation.
Nevertheless, significant innovation, driven by businesses like Ellex, is enabling ophthalmologists to secure new levels of treatment outcomes.
Our technology, which has been trialed, verified and proven, is producing breakthroughs in accuracy, efficacy and patient satisfaction, and it’s also making a positive contribution to reducing the requirement for medication.
The investment that our growing global community of ophthalmologists has made in Ellex technology is delivering a significant return — for them and their patients.
Optometrists and General Practitioners are frequently on the front line of the ophthalmic treatment journey.
It’s often within routine eye testing that conditions or symptoms are revealed that require further investigation before a procedural pathway can be identified and implemented.
Ellex is equipping more and more ophthalmologists around the world with the technology to secure new levels of treatment outcomes for the patients that you meet every day.
Ellex equipment is safe, accurate, and effective. It’s achieving high levels of patient satisfaction, and it’s also making a positive contribution to reducing the requirement for medication.
Quantel Medical has completed its acquisition of Ellex, including the company’s laser and ultrasound technology solutions (with the exception of 2RT® and iTrack®), via the financial holding company Lumibird Medical.
The coming together of these two companies—both renowned in the field of ophthalmology—represents a real milestone in their history. Quantel Medical and Ellex have a shared heritage in the development of cutting-edge technologies for the diagnosis and treatment of the leading causes of blindness worldwide: glaucoma, cataracts, AMD and diabetic retinopathy.